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Caseous lymphadenitis (CL) is an infectious and zoonotic disease characterized by
the development of granulomas in the lymph nodes and internal organs of small
ruminants. The etiological agent of this disease is Corynebacterium pseudotuberculosis,
a Gram-positive and facultative intracellular bacterium. The conventional treatment for
CL consists of drainage and chemical cauterization of the lesions using a 10% iodine
solution. However, this type of treatment is not effective, due to iodine’s cytotoxic profile
and low antibacterial activity. Currently, silver nanoparticles (AgNPs) can be seen as an
alternative treatment for CL due to their antimicrobial activity and wound healing effects.
Therefore, the present study aimed to evaluate AgNPs as a post-surgical treatment
for CL. Twenty-nine goats and sheep with clinical signs of CL were selected. Surgical
intervention was performed to excise the caseous lesions. To treat the lesions, an
ointment formulation based on AgNP mixed with natural waxes and oils was used in
the experimental group, and the conventional treatment with 10% iodine was used
in the control group. Bacteria were isolated from the excised caseous material. The
animals were observed for 8 weeks after the surgical treatment, and blood samples
were taken weekly. The surgical wounds of sheep treated with AgNP healed faster, and
the surgical wound area was smaller during the observation period; the latter effect was
also observed in goats. AgNP-treated animals also had less purulent discharge and less
moisture in the surgical wounds. The AgNP-treated animals had lower leukocyte counts
and lower titers of anti-C. pseudotuberculosis antibodies. There was no statistically
significant difference between the groups with regard to the hemogram results. The
results of the susceptibility testing of C. pseudotuberculosis strains (T1, 1002, FRC41,
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and VD57 strains) and clinical isolates to AgNPs showed growth inhibition, even at low
concentrations. It can be concluded that post-surgical treatment of CL using the AgNP-
based ointment may be a promising tool in the control of CL, through faster healing,
decreased wound contamination, and no apparent toxic effects.
Keywords: antimicrobials, caseous lymphadenitis, nanotechnology, small ruminants, wound healing
INTRODUCTION
Caseous lymphadenitis (CL), an infectious disease caused by the
bacterium Corynebacterium pseudotuberculosis that affects small
ruminants, has a chronic and debilitating profile and a zoonotic
potential. CL is characterized by the development of granulomas
in the lymph nodes and in organs such as the spleen, lungs, liver,
and kidneys (Dorella et al., 2006). The disease is associated with
a decrease in the production of wool and meat, as well as a high
cost of treatment (Santiago et al., 2013).
A definitive diagnosis of CL is made through the isolation of
the etiologic agent from caseous material retrieved from lesions.
The only possible treatment currently conducted in sheep and
goat farms is drainage of the lesions with an application of a
10% iodine solution for chemical cauterization (de Farias et al.,
2018), a procedure that can hinder the healing process due to
the histotoxic profile of iodine (Punjataewakupt et al., 2019).
The secretion from the operatory wounds pose a potential risk
for environmental contamination since C. pseudotuberculosis can
survive for long periods in the soil at sheep and goat farms
(Spier et al., 2012).
The inappropriate use of antimicrobials has been a cause
of multidrug-resistant bacteria development. In response,
conventional antibiotics are being substituted by new alternative
technologies such as nanotechnology, which has broad potential
use in human and veterinary medicine (Rudramurthy et al.,
2016). Silver nanoparticles (AgNPs) are seen as a good option
among nanoparticles with antimicrobial activity because, besides
having a marked antibacterial profile, they also contribute to
wound healing, are durable and efficacious, and are relatively
inexpensive to produce (Lee et al., 2007; Zang et al., 2008).
It is necessary that new compounds be developed for the post-
surgical treatment of CL. Given the antibacterial activity and
wound healing effects of AgNP, this study aimed to verify the
efficacy of a biogenic AgNP topical ointment in the treatment of
sheep and goats who underwent extraction of CL lesions.
MATERIALS AND METHODS
Animals and Ethical Aspects
This study was carried out in a sheep and goat breeding farm in
the municipality of Capim Grosso, Bahia State, Brazil. Twenty-
nine mixed breed animals with clinical signs of CL were selected.
These animals had a complete surgical removal of the CL lesions
with a standardized incision size and were divided into four
groups: group CP (10 goats treated with AgNP ointment); group
CI (10 goats treated with 10% iodine solution); group OP (5 sheep
treated with the AgNP-based ointment); and group OI (4 sheep
treated with 10% iodine solution). All the animals were treated
at the time of the CL lesion excision. The clinical, serological,
hematological, and biochemical follow-up was carried out shortly
before the surgical procedure and within 8 weeks after the surgical
procedure. This study was approved by the Committee on the
Use of Animals in Scientific Experimentation of the School of
Veterinary Medicine of the Federal University of Bahia (protocol
number 35/2017).
Biogenic AgNP Synthesis
The synthesis of the AgNPs was performed following the
procedure described by Ballottin et al. (2017). Briefly, Fusarium
oxysporum fungus was grown in a solid culture medium
consisting of 0.5% yeast extract, 2% malt, 2% agar and distilled
water, and kept at 28◦C for 1 week. After growth, sterilized
distilled water was added to the culture under constant stirring
until reaching a protein concentration of 0.1 g/mL and kept under
stirring for 72 h. A vacuum filtration was performed and then
0.01 mol/L of AgNO3 was added to the supernatant. The solution
was maintained at 28◦C and sealed with aluminum foil until the
formation of the nanoparticles. The AgNPs were characterized
and showed sizes of 28.0 ± 13.1 nm, polydispersity of 0.231,
zeta potential of −31.7 ± 2.8 mV, and were spherical in form
(Stanisic et al., 2018).
AgNP Ointment Production
For the post-surgical treatment of CL, an ointment based on
AgNPs, natural waxes, and oils was made, as described by Stanisic
et al. (2018). In the first step of ointment production, the oils and
waxes (31% solid vaseline, 20% lanoline, 10% liquid vaseline, 9.0%
cera alba, 8.0% cetostearyl alcohol, and 2.0% cholesterol) were
blended and heated at 60◦C until the mixture was homogeneous,
and all of the ingredients were fused. Then, the emulsion was
cooled to room temperature (25◦C), while constantly mixing
to maintain its homogeneity. In the second step of ointment
production, 20% part-to-part of a 12.8 mg/mL colloidal solution
of biogenic AgNPs was added gradually to the mixture at room
temperature under constant stirring (Stanisic et al., 2018). The
final ointment was a gray oil/water cream that was easy to apply
and left an oily film when applied to the skin surface.
Bacterial Strains
For the in vitro analysis of bacterial susceptibility to AgNPs,
we used four C. pseudotuberculosis strains: the 1002 strain,
which is used as a reference in the genome project of the
bacteria (Mariano et al., 2016) and has already had its whole
genome sequenced (GenBank CP001809.2); the VD57 strain,
which is a highly virulent strain isolated from a goat CL lesion
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(Almeida et al., 2016) that has a sequenced genome (GenBank
CP009927.1); the FRC41 strain, which was isolated from a human
case of lymphadenitis in France (Join-Lambert et al., 2006), and
also has a sequenced genome (GenBank CP013146.1); and the
T1 strain, which is an attenuated strain used as a CL vaccine
model (Moura-Costa et al., 2008), and also has a sequenced
genome (GenBank CP015100.1). All the C. pseudotuberculosis
strains herein used belong to the biovar ovis.
Isolation of C. pseudotuberculosis From
Caseous Lesions
For the isolation of C. pseudotuberculosis from the granuloma
material, caseous samples collected from the animals that
underwent the CL lesion excision were inoculated into Brain
and Heart Infusion agar (HIMEDIA, Mumbai, India) and
supplemented with 5% sheep blood. After inoculation, the
plates were incubated for 48 h at 37◦C. The isolated colonies
were macroscopically characterized, stained using the Gram
method, and subjected to biochemical tests. Colonies that
were Gram-positive, exhibited catalase production, demonstrated
positive reactions in the glucose, maltose, sucrose, and urea
tests, and negative reactions in the lactose, trealose, salicin,
and motility tests were identified as C. pseudotuberculosis
(Moura-Costa et al., 2008).
Determination of C. pseudotuberculosis
Laboratorial Strains and Clinical
Isolates Susceptibility/Resistance to
AgNP Profile
The broth microdilution methodology was performed according
to Norman et al. (2014), with modifications. The AgNP solution
was diluted in sterile milliQ water in concentrations ranging
from 7.5 to 0.02 mg/mL. The strains were inoculated in BHI
broth (HIMEDIA, Mumbai, India) Tween 80 0.1% for 12 h
prior to the assay. After incubation, the strains were diluted in
2 × BHI to achieve an optical density of 0.08–0.10 at 600 nm,
which contains 3 × 106 CFU/mL of C. pseudotuberculosis.
Subsequently, these suspensions were diluted in BHI broth to
obtain a concentration of 1 × 106 CFU/mL. One hundred µL
of the inoculum and 100 µL of the AgNP colloidal solution were
placed in each well. Two controls were used for each dilution, one
positive (bacterial suspension without AgNPs) and one negative
(AgNP colloidal solution without bacterial inoculation). Plates
were then incubated for 48 h at 37◦C. Analysis was performed
in a spectrophotometer at the wavelength of 600 nm and the
minimal concentration that inhibited 100% of the bacterial
growth (MIC100) was established. Then, 20 µL of each well
was removed and inoculated into BHI agar plates, which were
incubated for 48 h at 37◦C. Minimal bactericidal concentration
(MBC100) was defined as the lowest concentration capable of
killing all bacteria.
Surgical Procedure
Before the surgical incision, the hair in the skin above the CL-
affected lymph node was shaved, followed by a 70% alcohol
asepsis. For the surgical treatment, a 2 cm long standard incision
was made with a #4 scalpel blade on the CL lesions with
subsequent drainage of all the caseous material. This material
was collected in sterile containers and sent to the laboratory
to confirm the presence of C. pseudotuberculosis through
microbiological assays. In CI and OI groups, a commercial 10%
iodine solution was used in the surgical wound. In the CP
and OP groups, the AgNP ointment was added to the surgical
lesion, filling all space left by the drainage of the caseous lesion
(Supplementary Figure S1). The clinical, hematological and
serological follow-up of the animals were performed immediately
before and after the surgical procedure, and within 8 weeks
after the surgery, with a 1-week interval between observations
and collections. The animals’ cardiac and respiratory rate, rectal
temperature, body score, and skin turgor return time were
evaluated during the observation period.
Lesion drainage occurred in a location the herd could not
access, and, in order to reduce environmental contamination,
treated animals only returned to the herd after the lesion had
completely healed. Jugular venipuncture was performed just
before the surgery and weekly for 8 weeks following surgery.
Blood was collected (10 mL) in a Vacutainer R©-type tube without
anticoagulant. Samples were then centrifuged at 4000 × g for
10 min and the serum was obtained. These samples were used
in the serological tests. Also, blood samples (10 mL) were
collected in Vacutainer R© tubes with ethylenediaminetetraacetic
acid (EDTA) anticoagulant to perform blood cells counts using
an automatized counter. The area of open the surgical wounds
were measured using a caliper over the course of the 8 weeks of
post-surgical follow-up.
Immunological Assay
To detect C. pseudotuberculosis-specific antibodies in the animals’
serum samples, it was used serum samples collected from the
animals during the observation period. The serum samples were
analyzed using the indirect ELISAs developed by Rebouças et al.
(2013) for sheep and by Seyffert et al. (2010) for goats.
Statistical Analysis
The statistical analyses were conducted using SPSS 18 (IBM,
United States). The unpaired Student t-test was used to compare
blood cell counts, open wound areas, body and hydration scores,
and ELISA results between groups. Data from animals that had
moisture and purulent secretion in their surgical wounds and
the presence of lymph node enlargement were compared using
the chi square test. The curves of bacterial growth inhibition by
AgNPs, as well as the surgical wounds healing, were compared
using the Wilcoxon signed rank test. Values with p < 0.05 were
considered statistically significant.
RESULTS
Susceptibility of C. pseudotuberculosis
Strains and Clinical Isolates to AgNP
Evaluation of the C. pseudotuberculosis standard strain’s
susceptibility to AgNP using the broth microdilution method
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TABLE 1 | Susceptibility of C. pseudotuberculosis strains to AgNP.
Host Strain MIC100 (mg/mL) MBC100 (mg/mL)
Goat 1002 0.625 0.625
Human FRC41 0.625 1.25
Goat T1 0.625 1.25
Goat VD57 7.5 >7.5
A microdilution in broth assay was carried out with different AgNP dilutions (0.02–
7.5 mg/ml). MIC100 is defined as the AgNP concentration where there was inhibition
of 100% of bacterial growth, and MBC100 as the AgNP concentration where there
was 100% of bactericidal action, in mg/ml.
(Norman et al., 2014) indicated a 100% inhibition of the growth
of T1, 1002, and FRC41 strains at a 0.625 mg/mL concentration
of AgNP. The virulent strain VD57 showed MIC100 only at an
AgNP dilution of 7.5 mg/mL. Similar results were observed for
the minimal bactericide concentration values, with a MBC100
of 1.25 to 0.625 mg/mL for the 1002, FRC41, and T1 strains.
We observed no bactericidal action for VD57 in the AgNP
concentrations used in this experiment (Table 1). When
comparing the growth inhibition curves, the 1002, T1, and
FRC41 strains demonstrated a similar pattern of inhibition, but
were statistically different from the VD57 curve on the Wilcoxon
signed rank test (Figure 1).
As for the clinical isolates obtained from the animals
included in this study, the AgNP concentration of 0.156 mg/mL
inhibited 100% of the growth of 11 isolates. Two isolates
showed a high susceptibility to AgNP, with 100% inhibition
of growth up to the AgNP concentration of 0.02 mg/mL. The
concentrations of 0.040 mg/mL and 0.080 mg/mL together
demonstrated MIC100 for six isolates. Eight clinical isolates
showed less susceptibility, with inhibition of 100% growth at a
concentration of 0.312 mg/mL AgNP. Two isolates demonstrated
MIC100 at a concentration of 0.625 mg/mL AgNP. The
MBC100 ranged from 0.020 to 0.625 mg/mL, and only three
isolates demonstrated the maximum MBC100 of 0.625 mg/mL
(Supplementary Tables S1, S2).
Evaluation of Surgical Wounds
As shown in Figure 2, surgical wounds of sheep treated with
AgNP ointment took an average of 16.3 days to completely
heal, while those treated with 10% iodine took an average of
24.5 days. Post hoc analysis revealed that this difference was
significant (p < 0.05). The surgical wounds of nanoparticle-
treated goats took approximately 18 days to completely heal, and
those of 10% iodine-treated goats took an average of 23 days
to completely heal. This result was not significantly different at
p < 0.05. Associated with the faster wound healing, it could also
be observed that the hair around the surgical wounds in the
AgNP-treated animals grew faster (Supplementary Figure S2).
Regarding the area of the surgical wounds (Figure 3), AgNP-
treated goats presented a significant difference when compared
to those treated with 10% iodine 1 and 4 weeks after the surgical
procedure. The areas of the wounds were also smaller. The
AgNP-treated sheep presented significant differences in surgical
wound areas 4 and 5 weeks after removal of the caseous material
when compared to those treated with 10% iodine (p < 0.05).
The healing curve of AgNP-treated sheep was also significantly
different from that of animals treated with 10% iodine at the
Wilcoxon signed rank test (p < 0.05).
Regarding the presence of purulent secretion in surgical
wounds, Figure 4A expresses the number of events observed
during 8 weeks after the surgical procedure. Goats treated with
iodine demonstrated purulent secretion in their wounds in
FIGURE 1 | Inhibition of C. pseudotuberculosis strains growth by different concentrations of AgNP. The results are expressed as the means of three different
experiments. The curves of inhibition were statistically compared using the Wilcoxon signed-rank test, and the symbol “∗” indicates statistical difference with
p < 0.05.
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FIGURE 2 | Average number of days needed for complete wound healing after the surgical procedure for the treatment of caseous lymphadenitis (CL). Twenty goats
were used (10 treated with 10% iodine solution and 10 with AgNP ointment) and 9 sheep (four treated with 10% iodine solution and five with AgNP). The symbol “∗”
indicates statistical difference with a p < 0.05 using the unpaired Student t-test.
FIGURE 3 | Areas of open surgical wounds in (A) 20 goats, 10 treated with 10% iodine solution and 10 with nanoparticle ointment, and (B) 9 sheep, 4 treated with
10% iodine solution, and five with AgNP ointment, after the CL surgical treatment. The means of each point were statistically compared using the unpaired t test and
the “∗” symbol indicates statistical difference at p < 0. The healing curves are compared using the Wilcoxon signed rank and the symbol “∗∗” indicates statistical
difference between the curves at p < 0.05.
significantly more observations (20%) than those treated with the
ointment (5%). In sheep, we observed pruritic discharges in the
wounds of iodine-treated animals in 28% observations, whereas,
in AgNP-treated sheep, this discharge was only observed once
(2.5%). This difference was significantly different at the chi square
test (p < 0.05).
Regarding the presence of moisture in the surgical wounds
(Figure 4B), in both goats and sheep treated with AgNPs, humid
wounds were observed in 6.25 and 2.5% of the observations,
respectively. This was significantly different compared to
animals treated with 10% iodine. Lymph node enlargement
in goats treated with AgNPs was detected in 17.5% of the
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FIGURE 4 | Presence of (A) purulent secretion and (B) moisture in surgical
wounds an (C) detection of lymph node enlargement in animals treated with
iodine or AgNP ointment after removal of CL lesions. The data express the
number of events observed over the course of 8 weeks after the surgical
procedure. The symbol “∗” stands for statistical difference between the iodine
group and the group treated with nanoparticles at p < 0.05 using the chi
square test.
observations, while iodine-treated animals demonstrated lymph
node enlargement in 52.25% of the observations, which was
significantly different at the chi square test at p < 0.05
(Figure 4C). In sheep, there was no statistical difference in
the occurrence of lymph node enlargement cases when the two
treatments were compared.
Clinical Post-surgical Evaluation of the
Animals Treated With the AgNP Ointment
and Iodine 10%
The animals of this study were evaluated over a 2-month
period, between May and July of 2017, in the municipality of
FIGURE 5 | Clinical parameters of the animals that underwent the surgical
procedure for CL lesions and treatment with iodine or AgNP. It were assessed
the (A) cardiac rate (expressed in beats per minute), (B) respiratory rate
(expressed in movements per minute), and (C) the rectal temperature
(expressed in Celsius grades). The data are presented as the means of the
groups at each moment of observation, and no statistical differences were
seen between the groups at any evaluation point using the unpaired Student
t-test (p < 0.05).
Capim Grosso, Bahia State, Brazil. The average temperature in
this location during this time of year is 28◦C. The ambient
temperature was constant during the course of this experiment.
Figure 5 shows that, throughout the experiment, cardiac, and
respiratory rate and rectal temperature presented little variation
and there was no statistical significance between the two
experimental groups at any time. Regarding the mean body
scores, there was no statistical difference between the groups.
Mean hydration levels, measured using the skin return time
following the skin turgor test, were within normal limits, and
no statistical difference was found between the two treatment
groups (Figure 6). It is noteworthy to state that no clinical sign
of dermatitis, photosensitivity or hypersensitivity was observed
in animals treated with the AgNP ointment.
Blood Cell Counts
In the evaluation of hemogram results (quantification of red
blood cells, hemoglobin, globular volume, and mean globular
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FIGURE 6 | Determination of the (A) body score and the (B) skin turgor return
time of animals treated with iodine or AgNP ointment. Results are presented
as the means of each observation time for each group and the bars indicate
their respective standard deviations. No statistical differences were seen
between the groups at any evaluation point using the unpaired Student t-test.
volume), there was no statistically significant difference in either
goats or sheep treated with AgNPs compared to those treated
with iodine, and the values remained within the reference values
described for small ruminants (Weiss and Wardrop, 2016). In
the leukogram, the leukocyte count in iodine-treated goats was
statistically higher than goats treated with AgNPs 5 to 8 weeks
after the surgical treatment, with a statistical significance at the
seventh and 8 week (p < 0.05). For sheep, the leukocyte count of
iodine-treated animals was statistically higher from 4 weeks after
the surgical procedure until the end of the observation period, as
demonstrated in Figure 7.
Immunological Assay
The detection of IgG immunoglobulins specific for
C. pseudotuberculosis (Figure 8) demonstrated that, for
both sheep and goats, production of specific antibodies peaked
soon after the surgical intervention, but these levels normalized
during the experiment. For goats, there was a higher production
of C. pseudotuberculosis specific antibodies in the iodine-treated
group in the first week, which was statistically different when
compared to the AgNP-treated group. In sheep, differences
between treatment groups occurred during the first 2 weeks
after the surgical procedure, with specific antibody levels in the
iodine-treated group higher than the AgNP-treated group, when
values were compared by the unpaired Student t-test (p < 0.05).
DISCUSSION
The present study examines the effectiveness of AgNP-ointment
as an alternative post-surgical treatment of CL in small
ruminants. For a more complete verification of this application,
verification of the clinical parameters of the treated animals, in
addition to bacteriological tests, were conducted with standard
strains, and clinical isolates of the bacterium.
The results of the broth microdilution susceptibility test
confirmed that AgNPs demonstrated high efficacy in inhibiting
the growth of three standard strains of C. pseudotuberculosis
(T1, 1002, and FRC41) and clinical isolates collected from
FIGURE 7 | Total leukocyte counts of iodine or AgNP-treated goats (A) and sheep (B) after surgical removal of CL lesions. The means of each group at each point
were compared using the unpaired Student t-test. The symbol “∗” represents a statistical difference at p < 0.05. The internal lines of each graph represent the lower
and upper values of the reference value according to Weiss and Wardrop (2016).
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FIGURE 8 | Detection of anti-C. pseudotuberculosis-specific antibodies in (A)
goats and (B) sheep after surgical removal of CL lesions and treatment with
iodine or AgNP ointment. The results are expressed as the means of optical
densities per group by collection point. The bars represent the standard
deviations. The means of each group at each point were compared using the
unpaired Student t-test. The symbol “∗” represents a statistical difference at
p < 0.05.
animals with caseous lesions, even at high dilutions. This finding
agrees with studies showing the effectiveness of AgNPs against
other bacteria, such as Pseudomonas aeruginosa, Escherichia coli,
and Salmonella Typhi (Franci et al., 2015). Singh et al. (2013)
tested bacterial strains of Staphylococcus aureus and Streptococcus
mutans that exhibited resistance to β-lactam antibiotics and
showed that the addition of AgNP reduced the minimal
inhibitory concentration to the antibiotics and made the bacteria
more susceptible to antibiotic treatment. In addition, it has been
shown that AgNPs can be used as a topical drug owing to its high
stability and low toxicity (Singh et al., 2013).
Regarding the lower susceptibility of the VD57 strain, it
should be taken into account that VD57 is a highly virulent strain
with a high replication rate and is well adapted to the culture
conditions due to its long isolation time (Moura-Costa et al.,
2008; Almeida et al., 2016). Although the relationship between
virulence and susceptibility of Corynebacteria to antibiotics is
not described, this relationship was observed in Mycobacterium
tuberculosis (Rastogi et al., 1996), and in Klebsiella pneumoniae
(Padilla et al., 2010).
It should be noted that, even though in vitro results
demonstrated significant AgNP antimicrobial activity, in vivo
CL treatment is difficult, because several characteristics of
C. pseudotuberculosis infection and CL pathogenesis hamper the
contact of drugs with the pathogen and provide some protection
against certain antibiotics commonly used in the treatment of
the disease. Among these factors, the presence of a thick fibrous
capsule around the typical lesions, the caseous characteristic of
the lesion, and even the intracellular nature of the organism
during parts of the disease cycle can be seen (Williamson,
2001; Baird and Fontaine, 2007). Therefore, surgical excision of
granulomatous lesions is still the most feasible option compared
to systemic treatment with antimicrobial agents. Antibiotic drugs
would be of greater importance in post-surgical treatment of the
disease, since they inhibit environmental contamination (if the
procedure is not done well and the lesion material continues to
be released) or limit the spread of the pathogen in the animal
after the lesion is broken. Thus, AgNP-containing ointment
is possibly an effective treatment against CL, as it has good
antimicrobial activity, a significant effect against bacteria resistant
to antimicrobial agents, and its action is more concentrated on
the physical aspects of the membrane, and therefore, is less likely
to induce resistance (Apte et al., 2013; Rahisuddin et al., 2015;
El-Batal et al., 2016; Halbus et al., 2017).
AgNP-treated animals demonstrated faster healing with a
smaller area of the surgical lesion. It is worth noting that the
wound healing process is complex and involves inflammation,
granulation tissue formation, re-epithelization, and extracellular
matrix remodeling (Chu et al., 2012; Heydarnejad et al., 2013;
Chai et al., 2018). The clinical treatment of wounds remains
a challenge in surgical procedures as the selected treatment
should facilitate the healing process without producing harmful
side-effects. Wound disinfection with 10% iodine solution is
routinely used as the post-surgical treatment of LC but has several
drawbacks; it is histotoxic and can disrupt the cicatrizing process
(Burd et al., 2007; Santiago et al., 2013). This situation was
observed in this study, as animals treated with iodine required
a longer time for wound healing in both sheep and goats.
Recent studies have described the topical application of AgNPs
for wound healing. Naraginti et al. (2016), who compared
AgNPs with 1% soframycin, found that the healing time in
rats, treated with gold nanoparticles, and AgNPs, was an
average of 14 days after experimental surgery, whereas the
group treated with 1% soframycin presented a delayed healing.
Stojkovska et al. (2018) compared wound healing under AgNP
treatment with commercial silver sulfadiazine cream and found
that the AgNP-treated wounds took approximately 19 days
to resolve, while the silver sulfadiazine-treated group took
21 days. Another recent study, described by Chai et al. (2018),
observed, in humans, the resolution of AgNP-treated wounds
in 17 days, 9 days sooner than the control treatment. The
results obtained in the aforementioned studies align with the
findings in the current study for both goats (18 days) and
sheep (16 days).
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Naraginti et al. (2016) also verified that the healing action
of the nanoparticles in their study was most notable during
the initial stages of wound healing, which resulted in a
substantial reduction of open wound areas in the entire
healing period. This effect was also observed in the current
experiment; within the first week after the surgical procedure,
the wound size in AgNP-treated animals was smaller than in
the iodine-treated animals. This finding may be due to the fact
that AgNPs present pronounced antimicrobial activity (Halbus
et al., 2017). Their use in managing difficult-to-heal wounds
can reduce the time required for tissue repair through anti-
inflammatory effects and the prevention of wound colonization
by opportunistic agents (Sandri et al., 2012; Stojkovska et al.,
2018). Another study conducted by Silva et al. (2017) described
that AgNPs induced a greater reduction in wound area by
contraction, had low cytotoxicity, and promoted the growth
of hair on the surface of the wound in a manner similar to
that seen on the skin near the incision area. In our study,
we were able to observe that wounds in animals treated
with AgNPs not only healed faster, but also presented a
faster hair growth.
Several studies report the healing potential of AgNPs, such
as Galandáková et al. (2016), which demonstrated that AgNPs
induce the release of a series of pro-inflammatory markers in
several cell types, which accelerate healing. Stojkovska et al.
(2018) stated that the decrease in wound area depends on
contraction, as evidenced by Adibhesami et al. (2017) who
found that AgNPs revert the inflammatory process in less
time compared to antibiotics. In this study, not only did
animals treated with iodine demonstrate more cases of pruritic
exudate, but their wounds also maintained a moist environment
ideal for bacterial growth. The increased purulent secretion
observed in animals treated with iodine may be justified
not only by the fact that iodine does not have an overall
bactericidal action, but also because its use as an antiseptic
has some disadvantages such as dermal irritation and a greater
tendency to prolong inflammation (Iwasawa and Nakamura,
2003). It should be noted that animals in this study have
not been treated for possible new CL lesions because it is
believed that this would interfere with the immunological
and hematological data of the animals. This non-isolation of
the bacterium in new cases of lymphadenomegaly prevents
the affirmation that further lymph node enlargement cases in
animals treated with AgNPs may be due to C. pseudotuberculosis
itself, however, it can be speculated that there was an
inhibition of new infections by several bacterial agents that are
sensitive to the AgNPs.
Several studies have shown that the temperature increase
in different seasons may influence clinical parameters, such as
cardiac and respiratory rates and rectal temperature (Marai
et al., 2007). In our study, the temperature was constant for
the duration of the experimental period, reducing environmental
influences on these parameters. Similar values for the clinical
parameters were observed across groups during the study period,
and these parameters remained within the normal ranges (Riedi
et al., 2018). This result reflects the fact that the treatment with
AgNP-based ointment did not induce side-effects that would
result in changes in these parameters. There were also no
statistically significant differences in body and skin turgor return
time scores. These findings indicate that the AgNP ointment
did not induce physical side-effects, such as the development
of hypersensitivity reactions, fever, or dermatitis. Pulit et al.
(2011) cited that the contact of humans with AgNPs may cause
adverse effects, and these different results may have been due
to the different composition and thickness of the skin of small
ruminants and humans. Another aspect to be considered is the
size of the AgNPs, since Kang et al. (2017) described that 5 nm
AgNPs amplify the clinical features of atopic dermatitis, and Park
et al. (2011) found that 4 nm AgNPs presented a higher cytotoxic
effect than AgNPs at high concentrations with 20 and 70 nm sizes.
The AgNPs studied herein have an average size of 28 nm, and this
characteristic can then be associated with a lower occurrence of
adverse effects.
The results of the hemogram for both goats and sheep
treated with AgNPs were within normal range, demonstrating
that there were no toxic effects that could be expressed in
hematological constituents. Similar results were observed in
rabbits (Karavana et al., 2012), and humans (Chai et al., 2018),
in which AgNPs showed low cytotoxicity. The higher leukocyte
counts found in the animals treated with iodine, compared
to those treated with AgNPs, are possibly due to iodine-
related increases in levels of inflammation in ruminants due
to tissue toxicity, and possibly due to fact that the topical
application of nanoparticles are more effective in the suppression
of inflammation (Naraginti et al., 2016). This has a consequent
reduction of the presence of secondary bacterial infection in the
small ruminants.
Immunity to C. pseudotuberculosis is attributed to humoral
and cellular mechanisms (Lan et al., 1998). Humoral immunity
is important in the fight against C. pseudotuberculosis since
antibodies neutralize bacterial exotoxins, avoiding their
dissemination in the host (Vale et al., 2016). The results obtained
in this study regarding the detection of anti-C pseudotuberculosis
specific antibodies, for both sheep and goats, demonstrated
a higher production of these antibodies in the iodine-treated
group of animals than in the AgNP-treated animals during the
initial period of analysis. Goats and sheep that do not receive
treatment after infection by C. pseudotuberculosis have a high
humoral immune response for 70 days with peaks in the first
weeks following removal of the lesions, and antibody titers
beginning to decline after this period (Solanet et al., 2011).
The lower titers of antibodies may be related to the absorption
of AgNPs by the damaged skin, preventing the occurrence of
antigenic stimuli by disseminated bacteria at the time of the
surgical procedure. This absorption effect has already been
described (Salomoni et al., 2017; Galbiati et al., 2018). Therefore,
a lower infectious post-treatment load may warrant the lower
titer of antibodies.
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